Probiotics and prebiotics as a therapeutic strategy for inflammatory bowel disease.

dc.contributor.author	Geier, Mark Steven	en
dc.contributor.school	School of Molecular and Biomedical Science : Physiology	en
dc.date.issued	2007	en
dc.description	Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library.	en
dc.description.abstract	The primary aim of this thesis was to identify probiotics and/or prebiotics with the potential to reduce the severity of experimental colitis. The specific aims were to i) screen a range of candidate pro biotic strains for capacity to reduce symptoms of DSS-colitis, ii) characterize the effects of DSS within the small intestine, iii) assess, in vitro, the effect of probiotics on intestinal epithelial cell integrity, iv) assess the potential for the prebiotic, fructooligosaccharide, to reduce the severity of DSS-colitis alone, and in synbiotic combination with a probiotic strain.	en
dc.description.dissertation	Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Sciences, 2007	en
dc.identifier.uri	http://hdl.handle.net/2440/57412
dc.subject	inflammatory bowel diseases treatment; intestines microbiology; microorganisms therapeutic use; bacteria health aspects	en
dc.title	Probiotics and prebiotics as a therapeutic strategy for inflammatory bowel disease.	en
dc.type	Thesis	en

Files

Now showing 1 - 1 of 1